Loading...
•
Mar 31, 2021
Chemours Q1 2021 Earnings Report
Chemours' first quarter 2021 results were strong, with increased full-year 2021 outlook.
Key Takeaways
Chemours reported strong first quarter results with net sales of $1.4 billion, a 10% increase year-over-year. The company raised its full-year Adjusted EBITDA guidance by $100 million and now expects Free Cash Flow to be greater than $450 million.
Net Sales of $1.4 billion, up 10% year-over-year
Net Income of $96 million with EPS of $0.57
Adjusted Net Income of $120 million with Adjusted EPS of $0.71
Adjusted EBITDA of $268 million
Chemours
Chemours
Forward Guidance
Chemours expects to deliver 2021 Adjusted EBITDA within a range of $1.1 to $1.25 billion and to generate greater than $450 million of Free Cash Flow.